Pharmacovigilance (PV) has evolved and grown more complex over the past 5 to 10 years due to increasing data volumes, evolving regulations, influence of emerging markets and the emerging social media and innovative technological advances. Fast detection of Adverse Drug Reactions (ADRs) could allow the pharmaceutical industry to anticipate and then to control more efficiently […]
Read More